{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:02:20Z","timestamp":1761663740769,"version":"3.41.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ijantimicag.2018.01.024","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T18:30:03Z","timestamp":1522780203000},"page":"768-774","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Antimicrobial susceptibilities and molecular typing of neisseria gonorrhoeae isolates at a medical centre in Taiwan, 2001\u20132013 with an emphasis on high rate of azithromycin resistance among the isolates"],"prefix":"10.1016","volume":"51","author":[{"given":"Yen-Hung","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Tsung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Hsing","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Ren","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"WHO","key":"10.1016\/j.ijantimicag.2018.01.024_bib0010"},{"key":"10.1016\/j.ijantimicag.2018.01.024_bib0015","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1016\/S1473-3099(17)30310-9","article-title":"Sexually transmitted infections: challenges ahead","volume":"17","author":"Unemo","year":"2017","journal-title":"Lancet Infect Dis"},{"author":"WHO","key":"10.1016\/j.ijantimicag.2018.01.024_bib0020"},{"key":"10.1016\/j.ijantimicag.2018.01.024_bib0025","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s12879-015-1029-2","article-title":"Current and future antimicrobial treatment of gonorrhoea\u2014the rapidly evolving Neisseria gonorrhoeae continues to challenge","volume":"15","author":"Unemo","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.01.024_bib0030","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1128\/AAC.01295-13","article-title":"Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance","volume":"57","author":"Shimuta","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.01.024_bib0035","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/jac\/dkp188","article-title":"Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales","volume":"64","author":"Chisholm","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.01.024_bib0040","first-page":"E","article-title":"Australian Gonococcal Surveillance Programme annual report, 2015","volume":"41","author":"Lahra","year":"2017","journal-title":"Commun Dis Intell Q Rep"},{"key":"10.1016\/j.ijantimicag.2018.01.024_bib0045","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1128\/AAC.00325-11","article-title":"Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone","volume":"55","author":"Ohnishi","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.01.024_bib0050","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1056\/NEJMc1408109","article-title":"A new multidrug-resistant strain of Neisseria gonorrhoeae in Australia","volume":"371","author":"Lahra","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2018.01.024_bib0055","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1128\/AAC.05760-11","article-title":"High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure","volume":"56","author":"Unemo","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.01.024_bib0060","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/jac\/dks162","article-title":"Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain","volume":"67","author":"Camara","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.01.024_bib0065","first-page":"339","article-title":"Surveillance of Gonococci-National Isolate Collection for Epidemiology (G-NICE), 2010","volume":"28","author":"Lin","year":"2012","journal-title":"Taiwan Epidemiol Bull"},{"key":"10.1016\/j.ijantimicag.2018.01.024_bib0070","first-page":"1","article-title":"Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ijantimicag.2018.01.024_bib0075","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/0956462412472837","article-title":"2012 European guideline on the diagnosis and treatment of gonorrhoea in adults","volume":"24","author":"Bignell","year":"2013","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.ijantimicag.2018.01.024_bib0080","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1056\/NEJMc1512757","article-title":"Failure of dual antimicrobial therapy in treatment of gonorrhea","volume":"374","author":"Fifer","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2018.01.024_bib0085","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijantimicag.2010.01.007","article-title":"Antimicrobial susceptibility of Neisseria gonorrhoeae isolates determined by the agar dilution, disk diffusion and Etest methods: comparison of results using GC agar and chocolate agar","volume":"35","author":"Liao","year":"2010","journal-title":"Int J Antimicrob Agents"},{"author":"European Committee on Antimicrobial Susceptibility Testing","key":"10.1016\/j.ijantimicag.2018.01.024_bib0090"},{"year":"2017","series-title":"Document M100-S27 performance standards for antimicrobial susceptibility testing; twenty-seventh informational supplement","author":"Clinical and Laboratory Standards Institute","key":"10.1016\/j.ijantimicag.2018.01.024_bib0095"},{"key":"10.1016\/j.ijantimicag.2018.01.024_bib0100","first-page":"173","article-title":"Multi-locus sequence typing","volume":"67","author":"Jolley","year":"2001","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.ijantimicag.2018.01.024_bib0105","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/jac\/dkt017","article-title":"Failure of 500\u2009mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia","volume":"68","author":"Y Chen","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.01.024_bib0110","doi-asserted-by":"crossref","DOI":"10.2807\/ese.16.06.19792-en","article-title":"Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010","volume":"16","author":"Unemo","year":"2011","journal-title":"Euro Surveill"},{"issue":"Suppl. 2","key":"10.1016\/j.ijantimicag.2018.01.024_bib0115","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.01.024_bib0120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/cid\/cix249","article-title":"Decreased azithromycin susceptibility of Neisseria gonorrhoeae isolates in patients recently treated with azithromycin","volume":"65","author":"Wind","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.01.024_bib0125","first-page":"3404","article-title":"Occurrence of high-level azithromycin-resistant Neisseria gonorrhoeae isolates in China","volume":"70","author":"Xue","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.01.024_bib0130","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/cid\/cir929","article-title":"Neisseria gonorrhoeae with high-level resistance to azithromycin: case report of the first isolate identified in the United States","volume":"54","author":"Katz","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.01.024_bib0135","doi-asserted-by":"crossref","first-page":"95","DOI":"10.33321\/cdi.2012.36.4","article-title":"Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian Regions, 2010","volume":"36","author":"Lahra","year":"2012","journal-title":"Commun Dis Intell Q Rep"},{"year":"2016","series-title":"European Centre for Disease Prevention and Control. Gonococcal antimicrobial susceptibility surveillance in Europe, 2014","author":"Unemo","key":"10.1016\/j.ijantimicag.2018.01.024_bib0140"},{"key":"10.1016\/j.ijantimicag.2018.01.024_bib0145","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2217\/fmb.12.117","article-title":"Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea","volume":"7","author":"Unemo","year":"2012","journal-title":"Future Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.01.024_bib0150","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1128\/AAC.00198-08","article-title":"Ceftibuten resistance and treatment failure of Neisseria gonorrhoeae infection","volume":"52","author":"Lo","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.01.024_bib0155","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1128\/AAC.46.12.3744-3749.2002","article-title":"Mosaic-like structure of penicillin-binding protein 2 Gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime","volume":"46","author":"Ameyama","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.01.024_bib0160","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/sti.2010.045377","article-title":"Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden","volume":"86","author":"Golparian","year":"2010","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.ijantimicag.2018.01.024_bib0165","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jiac.2017.03.007","article-title":"Ceftriaxone susceptibility and molecular characteristics of Neisseria gonorrhoeae isolates in Changsha, China","volume":"23","author":"Peng","year":"2017","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijantimicag.2018.01.024_bib0170","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1128\/AAC.02608-13","article-title":"Azithromycin resistance is coevolving with reduced susceptibility to cephalosporins in Neisseria gonorrhoeae in Ontario, Canada","volume":"58","author":"Allen","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"Pt 6","key":"10.1016\/j.ijantimicag.2018.01.024_bib0175","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1099\/00221287-140-6-1285","article-title":"Further evidence for the non-clonal population structure of Neisseria gonorrhoeae: extensive genetic diversity within isolates of the same electrophoretic type","volume":"140","author":"O'Rourke","year":"1994","journal-title":"Microbiology"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918300359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918300359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T11:32:50Z","timestamp":1751542370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857918300359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0924857918300359"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.01.024","relation":{},"ISSN":["0924-8579"],"issn-type":[{"type":"print","value":"0924-8579"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial susceptibilities and molecular typing of neisseria gonorrhoeae isolates at a medical centre in Taiwan, 2001\u20132013 with an emphasis on high rate of azithromycin resistance among the isolates","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.01.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}